RT100 100mg*10vials

Retatrutide RT100 100mg*10vials

Retatrutide is a triple-receptor agonist peptide that simultaneously activates GLP-1, GIP, and glucagon receptors, representing the highest-concentration metabolic research peptide available.

The 100mg single-vial specification delivers the maximum active ingredient load in the retatrutide product series. This premium formulation is designed for ultra-long-term large animal models, extreme high-dose gradient experiments, and the largest-scale multi-group parallel research projects. The exceptionally high concentration eliminates repeated dilution steps across very long experimental timelines, effectively reducing data deviation and operational errors from frequent solution preparation.

Dual GLP-1 and GIP pathway activation supports comprehensive research into insulin sensitivity, glycemic regulation, and appetite-related signaling mechanisms. The glucagon receptor component adds energy expenditure and lipid metabolism pathways for full-spectrum metabolic investigation.

This product is supplied as sterile lyophilized powder in glass vials, formulated for reconstitution with bacteriostatic water. Every batch undergoes comprehensive purity testing, with a full certificate of analysis provided.

10 vials per pack, designed for top-tier professional research institutions and large-scale global wholesale procurement.